期刊文献+

射频导管消融与药物室率控制治疗心房颤动合并心力衰竭患者的疗效比较 被引量:2

Catheter Ablation Versus Rate Control for Treatment of Heart Failure in Patients with Atrial Fibrillation
暂未订购
导出
摘要 目的比较射频导管消融(下称消融)的节律控制与药物室率控制对心房颤动患者心力衰竭的治疗效果。方法连续入选心房颤动合并心力衰竭患者35例(消融组),同期选择年龄、性别、心房颤动类型、基础疾病、左心房前后径(LAD)、左心室舒张末期内径(LVEDd)、左心室射血分数(LVEF)相匹配的药物室率控制加抗凝治疗的患者35例(室率控制组)。结果随访(24±12)个月,消融术后,57%(20/35)的患者维持窦性心律。消融组与药物室率控制组比较,其中心血管死亡事件发生率(5.71%vs 8.57%)差异无统计学意义(P>0 05),缺血性脑卒中发生率(2.86%vs 20.00%),NYHA心功能分级改善(68.57%vs 31.43%),LAD改变幅度[(-8±8)mm vs(9±12)mm],LVEDd改变幅度[(-5±7)mm vs(0±7)mm],LVEF提高幅度[(21%±12)%vs(10%±15%)]差异均有统计学意义(均P<0.05或0.01)。结论合并心力衰竭的心房颤动患者,经导管消融的节律控制优于药物室率控制。 Objective To compare the effect of catheter ablation and rate control strategy on heart failure (HF)of pa-tients with atrial fibril ation (AF). Methods 35 consecutive patients with AF and HF underwent catheter ablation(ablation group) and 35 similar patients received pharmacologic rate control and anticoagulation therapy (rate control group). Re-sults After a mean fol ow up of 24 ±12 months, sinus rhythm was seen in 57.14%(20 / 35) of the patients underwent catheter ablation. Compared with rate control group, ablation group had significantly less stroke events (2.86% vs. 20.00%, P〈0.05), more significantly improved NYHA class (68.57% vs. 31.43%, P〈0.01), decreased left atrial diameter (- 8±8mm vs. 9±12mm, P〈0.01) and left ventricular end diastolic diameter (- 5±7mm vs. 0±7mm, P〈0.01), and in-creased left ventricular ejection fraction (21%±12%vs. 10%±15%, P〈0.01). There was no significant difference of car-diac death between ablation group (5.71%) and rate control group (8.57%)(P〉0.05). Conclusion Rhythm control by catheter ablation is superior to pharmacologic rate control in improving heart function of patients with AF.
出处 《心电与循环》 2013年第5期382-384,392,共4页 Journal of Electrocardiology and Circulation
关键词 心房颤动 心力衰竭 导管消融 室率控制 Atrial fibrillation Heart failure Catheter ablation Rate control
  • 相关文献

参考文献12

  • 1Dries D L,Exner D V,Gersh B J. Atrial fibril ation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction:a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction[J].Journal of the American College of Cardiology,1998,(02):695-703.
  • 2Martin R. Karch,Bernhard Zrenner,Isabel Deisenhofer. Freedom from Atrial Tachyarrhythmias after Catheter Ablation of Atrial Fibril ation:A Randomized Comparison between 2 Current Ablation Strategies[J].Circulation,2005.2875-2880.
  • 3Mark D O'Neill,Pierre Jais,Yoshihide Takahashi. The stepwise ablation approach for chronic atrial fibril ation-Evidence for a cumulative effect[J].Journal of Interventional Cardiac Electrophysiology,2006.153-167.
  • 4Wang T J,Larson M G,Levy D. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality:the Framingham Heart Study[J].Circulation,2003.2920-2925.
  • 5Wyse D G,Waldo A L,DiMarco J P. A comparison of rate control and rhythm control in patients with atrial fibrillation[J].New England Journal of Medicine,2002.1825-1833.
  • 6Van Gelder I C,Hagens V E,Bosker H A. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation[J].New England Journal of Medicine,2002.1834-1840.
  • 7Pappone C,Augello G,Sala S. A randomized trial of circum-ferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation:the APAF Study[J].Journal of the American College of Cardiology,2006.2340-2347.
  • 8Stabile G,Bertaglia E,Senatore G. Cathetre ablation treatment in patients with drug-refractory atrial fibrillation:a prospective,multicentre,randomized,control ed study(Catheter Ablation for the Cure of Atrial Fibrillation Study)[J].European Heart Journal,2006.216-221.
  • 9Tondo C,Mantica M,Russo G. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function[J].Pacing and Clinical Electrophysiology,2006,(09):962-970.
  • 10Gentlesk P J,Sauer W H,Gerstenfeld E P. Reversal of left ventricular dysfunction following ablation of atrial fibril ation[J].Journal of Cardiovascular Electrophysiology,2007,(01):9-14.doi:10.1111/j.1540-8167.2006.00653.x.

同被引文献21

  • 1Caldeira D, David C, Sampaio C. Rate vs rhythm control in patients with atrial fibrillation and heart failure: a systematic review and mcta-analysis of randomised controlled trials. Eur J Intern Med,2011, 22:448-455.
  • 2Chatterjee S, Sardar P, Lichstein E, et al. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysio1,2013, 36 : 122-133.
  • 3Higgins J, Green S, Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, NJ : JohnWiley& Sons ,2008.
  • 4Wells G, Shea B, O' Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses,2012. URL: http://www, ohri. ca/programs/ elinical_epidemiology/oxford, asp.
  • 5Hunter R J, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablatior versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Cire Arrhythm Electrophysial,2014, 7:31-38.
  • 6Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coil Cardiol, 2013, 61 : 1894-1903.
  • 7Khan MN,Jais P, Cummings 3, et al. Pulmonary-vein isolationfor atrial fibrillation in patients with heart failure. N Engl J Med, 2008, 359 : 1778-1785.
  • 8MacDonald MR, Connelly DT, Hawkins NM, et al. Radiofrequeney ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventrieular systolic dysfunction : a randomised controlled trial. Heart ,2011, 97:740- 747.
  • 9Cha YM,Wokhlu A, Asirvatham SJ,et al. Success of ablation tot atrial fibrillation in isolated left ventrieular diastolic dysfunction : a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysio1,2011, 4:724-732.
  • 10Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coil Cardiol, 2004, 43 : 1004- 1009.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部